Bio Path Holdings sell me8
Start price
10.02.21
/
0%
€10.70
Target price
10.02.22
€8.00
Performance (%)
-29.44%
End price
11.02.21
€7.55
Summary
This prediction ended on 11.02.21 with a price of €7.55. The price of Bio Path Holdings decreased from the start of the prediction. Compared to the start price this resulted in a performance of -29.44%. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bio Path Holdings | - | - | - | - |
| iShares Core DAX® | 2.594% | -1.158% | 14.782% | 16.813% |
| iShares Nasdaq 100 | 3.553% | -1.727% | 43.265% | 44.227% |
| iShares Nikkei 225® | 0.687% | -8.354% | 18.454% | 1.361% |
| iShares S&P 500 | 2.209% | -0.942% | 31.361% | 42.812% |
According to me8 what are the pros and cons of Bio Path Holdings for the foreseeable future?
Pros
Capable Management
Cons
Probably not worthwhile Investment
Little innovation
Growths slower than the competition
Comments by me8 for this prediction
In the thread Bio Path Holdings diskutieren
Sell Bio Path Holdings
Kursziel gesetzt auf 8,0